T. Rowe Price Associates’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-20,700
| Closed | -$44K | – | 3030 |
|
2024
Q3 | $44K | Hold |
20,700
| – | – | ﹤0.01% | 2943 |
|
2024
Q2 | $30K | Hold |
20,700
| – | – | ﹤0.01% | 2895 |
|
2024
Q1 | $31K | Hold |
20,700
| – | – | ﹤0.01% | 2910 |
|
2023
Q4 | $32K | Hold |
20,700
| – | – | ﹤0.01% | 2848 |
|
2023
Q3 | $44K | Hold |
20,700
| – | – | ﹤0.01% | 2786 |
|
2023
Q2 | $48K | Hold |
20,700
| – | – | ﹤0.01% | 2802 |
|
2023
Q1 | $45K | Hold |
20,700
| – | – | ﹤0.01% | 2803 |
|
2022
Q4 | $42K | Hold |
20,700
| – | – | ﹤0.01% | 2831 |
|
2022
Q3 | $45K | Sell |
20,700
-22,400
| -52% | -$48.7K | ﹤0.01% | 2849 |
|
2022
Q2 | $109K | Hold |
43,100
| – | – | ﹤0.01% | 2736 |
|
2022
Q1 | $115K | Buy |
43,100
+11,600
| +37% | +$31K | ﹤0.01% | 2818 |
|
2021
Q4 | $84K | Hold |
31,500
| – | – | ﹤0.01% | 2889 |
|
2021
Q3 | $119K | Hold |
31,500
| – | – | ﹤0.01% | 2808 |
|
2021
Q2 | $134K | Sell |
31,500
-3,087
| -9% | -$13.1K | ﹤0.01% | 2792 |
|
2021
Q1 | $175K | Buy |
+34,587
| New | +$175K | ﹤0.01% | 2714 |
|